Elsevier Inc.

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Giralt
    Giralt
  3. Derkach
    Derkach
  4. Shah
    Shah
  5. Mailankody
    Mailankody
  6. Hassoun
    Hassoun
  7. Korde
    Korde
  8. Landau
    Landau
  9. Lesokhin
    Lesokhin
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (74)
  2. Population Sciences Research Program (74)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (62)
  5. Survivorship Research (46)
  6. Lymphoma (35)
  7. Epidemiology and Biostatistics (33)
  8. Biostatistics Service (31)
  9. Bone Marrow Transplant (25)
  10. Sloan Kettering Institute Postdocs (22)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (25)
  3. Book Section (1)
  4. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (74)
  2. Population Sciences Research Program (74)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (62)
  5. Survivorship Research (46)
  6. Lymphoma (35)

More Groups

People
  1. Steven Horwitz (31)
  2. Sergio Giralt (20)
  3. Andriy Derkach (17)
  4. Gunjan Shah (17)
  5. Malin Hultcrantz (16)
  6. Sham Mailankody (16)

More People

Years
  1. 2023 (11)
  2. 2022 (10)
  3. 2021 (7)
  4. 2020 (7)
  5. 2019 (4)
  6. 2018 (5)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (35)
  2. European Journal of Cancer (9)
  3. Biology of Blood and Marrow Transplantation (8)
  4. International Journal of Radiation Oncology, Biology, Physics (7)
  5. Gynecologic Oncology (3)
  6. Transplantation and Cellular Therapy (2)

More Publications

Results (74)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and outcome of extranodal NK/T-cell lymphoma in North America: A retrospective multi-institutional experience
    Journal Article

    Bennani, N. N.; Tun, A. M.; Carson, K. R.; Geiger, J. L.; Maeda, L. S.; Savage, K. J.; Rose, J.; Pinter-Brown, L.; Lunning, M. A.; Abramson, J. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
    Meeting Abstract

    Musiek, A. C. M.; Whittaker, S.; Horowitz, S. M.; Bagot, M.; Huen, A.; Fisher, D. C.; Haun, P.; Vermeer, M. H.; Ito, T.; Dwyer, K.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry
    Meeting Abstract

    Quaglino, P.; Ortiz-Romero, P.; Bagot, M.; Cozzio, A.; Evison, F.; Geskin, L.; Guenova, E.; Hodak, E.; Horwitz, S.; Papadavid, E.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • The ECHELON-2 trial: 5-year results of a randomized, double-blind, phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in frontline treatment of patients with CD30-positive peripheral T-cell lymphoma
    Meeting Abstract

    Iyer, S.; Trümper, L.; O'Connor, O. A.; Pro, B.; Illidge, T.; Advani, R.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domingo-Domenech, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
    Journal Article

    Kim, Y. H.; Prince, H. M.; Whittaker, S.; Horwitz, S. M.; Duvic, M.; Bechter, O.; Sanches, J. A.; Stadler, R.; Scarisbrick, J.; Quaglino, P.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Quality of life effect of the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat in patients with cutaneous T-cell lymphoma
    Journal Article

    Porcu, P.; Hudgens, S.; Horwitz, S.; Quaglino, P.; Cowan, R.; Geskin, L.; Beylot-Barry, M.; Floden, L.; Bagot, M.; Tsianakas, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Adult T-cell leukemia/lymphoma
    Book Section

    Lunning, M. A.; Mehta-Shah, N.; Horwitz, S. M.
    In Niederhuber, J. E.; Armitage, J. O.; Kastan, M. B.; Doroshow, J. H.; Tepper, J. E. (Eds.) Abeloff’s Clinical Oncology. 6th ed (2020)

    Fulltext@MSK | Save
  • High local control and overall survival with radiotherapy for anaplastic large cell lymphoma
    Meeting Abstract

    Wijetunga, N. A. A.; Lee, J.; Imber, B. S.; Modlin, L. A.; Ghione, P.; Khan, N.; Epstein-Peterson, Z.; Moskowitz, A. J.; Horwitz, S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save